TY  - JOUR
AU  - Aviles Bueno, Beatriz
AU  - Soler, Maria Jose
AU  - Perez-Belmonte, Luis
AU  - Jimenez Millan, Anabel
AU  - Rivas Ruiz, Francisco
AU  - Garcia de Lucas, Maria Dolores
PY  - 2022
DO  - 10.1093/ckj/sfac096
SN  - 2048-8505
UR  - http://hdl.handle.net/10668/19746
T2  - Clinical kidney journal
AB  - Semaglutide [glucagon-like peptide-1 receptor-agonist (GLP-1RA)] has shown nephroprotective effects in previous cardiovascular studies. However, its efficacy and safety in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) have been...
LA  - en
KW  - GLP-1RA
KW  - albuminuria
KW  - diabetic chronic disease
KW  - obesity
KW  - semaglutide
TI  - Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.
TY  - research article
VL  - 15
ER  -